Balance Sheet for Alder BioPharmaceuticals Inc. (ALDR)

$ 18.88 0.00 (0.00%) Volume: 250 4:00 PM EDT Oct 15, 2019
Pre-Market:  $ 18.90   0.02 (+0.11%) Volume: 250 9:00 AM EDT Oct 16, 2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 87,865 76,896 116,216 206,492 46,795
Restrictable Cash 5,000 - - - -
Marketable Securities 319,504 199,344 235,651 98,680 9,077
Accounts Receivable - - - - 113
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - 113
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - 2,808 936 - -
Inventories, Adjustments & Allowances - - - - -
Inventories - 2,808 936 - -
Prepaid Expenses 7,440 11,014 40,380 17,029 4,758
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 419,809 287,254 393,183 322,201 60,743
Land and Improvements - - - - -
Buildings and Improvement 7,696 4,914 5,269 1,850 1,602
Machinery, Furniture and Equipment 6,546 5,992 9,123 6,514 6,147
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 14,242 10,906 14,392 8,364 7,749
Gross Fixed Assets 14,242 10,906 14,392 8,364 7,749
Accumulated Depreciation (7,842) (5,276) (7,316) (6,390) (6,589)
Net Fixed Assets 6,400 5,630 7,076 1,974 1,160
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 30 10,030 8,030 12 36
Total Non-Current Assets 6,430 15,882 15,971 77,826 3,616
Total Assets 426,239 303,136 409,154 400,027 64,359
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 6,583 7,471 10,361 4,727 1,911
Short Term Debt - - - - -
Notes Payable - - - - -
Accrued Expenses 9,957 7,870 10,604 4,427 752
Accrued Liabilities 9,957 7,870 10,604 4,427 752
Deferred Revenues 74 92 92 62 135
Current Deferred Income Taxes - - - - -
Other Current Liabilities 11,622 7,933 4,833 3,156 2,211
Total Current Liabilities 28,236 23,366 25,890 12,372 5,009
Long Term Debt 182,104 - - - -
Deferred Income Tax 510 495 481 138 193
Other Non-Current Liabilities (101,587) 495 481 138 (111,181)
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 184,272 495 481 138 (111,181)
Total Liabilities 212,508 23,861 26,371 12,510 (106,172)
Preferred Shareholder's Equity 103,755 - - - 111,374
Common Shareholder's Equity 109,976 279,275 382,783 387,517 59,157
Common Par 7 7 5 4 3
Additional Paid in Capital 1,074,963 946,869 761,456 610,390 196,082
Cumulative Translation Adjustments - - - - -
Retained Earnings (963,938) (667,509) (378,630) (222,376) (136,906)
Treasury Stock - - - - -
Other Equity Adjustments (1,056) (92) (48) (501) (22)
Total Capitalization 395,835 279,275 382,783 387,517 170,531
Total Equity 213,731 279,275 382,783 387,517 170,531
Total Liabilities & Shareholder's Equity 426,239 303,136 409,154 400,027 64,359
Cash Flow (331,934) (288,879) (156,254) (85,470) 8,908
Working Capital 391,573 263,888 367,293 309,829 55,734
Free Cash Flow (253,986) (228,667) (166,306) (82,456) (48,306)
Invested Capital 395,835 279,275 382,783 387,517 59,157
Shares Outstanding - Common Class Only 68,411 67,843 50,368 43,707 30,997
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 68,411 67,843 50,368 43,707 30,997
Total Common Shares Outstanding 68,411 67,843 50,368 43,707 30,997
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 68,099 58,347 48,408 40,587 20,507
Diluted Weighted Shares Outstanding 68,099 58,347 48,408 40,587 29,427